Pulmonx Corp (LUNG) stock
LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/3040% below fair value
$2.86−0.14 (-4.67%)
Close on Nov 13, 2026Market cap $122.83MP/E –Yield –
Pulmonx cash
Cash and short-term investments held at the end of each period.
Pulmonx's cash was $52.69M at Sep 30, 2026. For fiscal 2025 it was $69.75M, down 2.0% from the year before. The highest annual figure on record is $231.79M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $69.75M | -2.0% |
| FY2024 | Dec 31, 2024 | $71.16M | -15.1% |
| FY2023 | Dec 31, 2023 | $83.78M | -40.7% |
| FY2022 | Dec 31, 2022 | $141.37M | -21.6% |
| FY2021 | Dec 31, 2021 | $180.27M | -22.2% |
| FY2020 | Dec 31, 2020 | $231.79M | +717.7% |
| FY2019 | Dec 31, 2019 | $28.35M | +587.4% |
| FY2018 | Dec 31, 2018 | $4.12M | -59.0% |
| FY2017 | Dec 31, 2017 | $10.05M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $52.69M | -31.2% |
| Q2 FY2026 | Jun 30, 2026 | $55.84M | -26.0% |
| Q1 FY2026 | Mar 31, 2026 | $61.57M | -17.4% |
| Q4 FY2025 | Dec 31, 2025 | $69.75M | -2.0% |
| Q3 FY2025 | Sep 30, 2025 | $76.55M | +20.9% |
| Q2 FY2025 | Jun 30, 2025 | $75.47M | +18.9% |
| Q1 FY2025 | Mar 31, 2025 | $74.56M | +6.3% |
| Q4 FY2024 | Dec 31, 2024 | $71.16M | -15.1% |
| Q3 FY2024 | Sep 30, 2024 | $63.31M | -33.3% |
| Q2 FY2024 | Jun 30, 2024 | $63.46M | -53.0% |
| Q1 FY2024 | Mar 31, 2024 | $70.16M | -54.1% |
| Q4 FY2023 | Dec 31, 2023 | $83.78M | -40.7% |
| Q3 FY2023 | Sep 30, 2023 | $94.95M | -39.5% |
| Q2 FY2023 | Jun 30, 2023 | $135.15M | -16.6% |
| Q1 FY2023 | Mar 31, 2023 | $152.84M | -10.1% |
| Q4 FY2022 | Dec 31, 2022 | $141.37M | -21.6% |
| Q3 FY2022 | Sep 30, 2022 | $156.90M | -22.6% |
| Q2 FY2022 | Jun 30, 2022 | $162.09M | -23.4% |
| Q1 FY2022 | Mar 31, 2022 | $170.08M | -23.2% |
| Q4 FY2021 | Dec 31, 2021 | $180.27M | -22.2% |
| Q3 FY2021 | Sep 30, 2021 | $202.60M | +409.0% |
| Q2 FY2021 | Jun 30, 2021 | $211.50M | +387.9% |
| Q1 FY2021 | Mar 31, 2021 | $221.60M | +1264.4% |
| Q4 FY2020 | Dec 31, 2020 | $231.79M | +717.7% |
| Q3 FY2020 | Sep 30, 2020 | $39.81M | +153.1% |
| Q2 FY2020 | Jun 30, 2020 | $43.35M | +951.1% |
| Q1 FY2020 | Mar 31, 2020 | $16.24M | +61.6% |
| Q4 FY2019 | Dec 31, 2019 | $28.35M | – |
| Q3 FY2019 | Sep 30, 2019 | $15.73M | – |
| Q4 FY2018 | Dec 31, 2018 | $4.12M | – |
| Q4 FY2017 | Dec 31, 2017 | $10.05M | – |
See a number that looks wrong?